Sheridan, M.B.; Bytyci, A.; Stinnett, V.; Umeh, C.; Mari, Z.; Dawson, T.M.; Bodurtha, J.; and Batista, D.A.S.: Myoclonus-dystonia and Silver-Russell syndrome resulting from maternal uniparental disomy of chromosome 7. Clin Genet, doi: 10.1111/cge.12075. [Epub ahead of print], PMID: 23237735, 2012
Umeh, C.C.; Nichols, P.; Rosenthal, L.S. and Mari, Z.: Dual treatment of hemichorea-hemiballismus syndrome with tetrabenazine and chemodenervation. Tremor Other Hyperkinet Mov (N Y), 2. doi:pii: tre-02-113-791-3, Epub 2012
Mari, Z.; Rosenthal, L.S.; Darwin, K.; Hallett, M. and Jinnah, H.A.: Clinical Reasoning: A 57 Year Old Man with Jaw Spasms. Neurology, 80(10):e104-7. doi: 10.1212/WNL.0b013e318285c14a, 2013
Probasco, J.C.; Sahin, B.; Tran, T.; Chung, T.H.; Rosenthal, L.S.; Mari, Z. and Levy, M.: Perioperative Neurological Consultation, The Neurohospitalist, DOI: 10.1177/1941874413476042, 2013
Zakaria, R.; Lenz, F.A.; Hua, S.; Avin, B.H.; Liu, C.C. and Mari, Z.: Thalamic physiology of intentional essential tremor is more like cerebellar tremor than postural essential tremor. Brain Res, doi:pii: S0006-8993(13)00976-1. 10.1016/j.brainres.2013.07.011. [Epub ahead of print], PMID: 23856324, 2013
Ramirez-Castaneda, J.; Jankovic, J.; Comella, C.; Dashtipour, K.; Fernandez, H.H. and Mari, Z.: Diffusion, Spread, and Migration of Botulinum Toxin. Mov Disord. doi: 10.1002/mds.25582. [Epub ahead of print] PMID: 23868503, 2013
Dr. Mari is a team member of the Johns Hopkins Morris K. Udall Parkinson's Disease Research Center of Excellence. The primary goal of the Udall Centers is to develop new clinical treatments for Parkinson's disease. However, it is well recognized that because there is so much that we do not yet understand about the causes of Parkinson's disease, basic science is currently a key component of the overall effort to develop clinical treatments. Over the last year, the Johns Hopkins Udall Center has made significant steps towards understanding the underlying mechanisms that cause Parkinson’s disease and have yielded promising targets for developing treatments against the disease.
Learn more about active clinical trials taking place at the Johns Hopkins Parkinson’s Disease and Movement Disorders Center.